“…33 However, on photoexcitation with visible light the ruthenium dppz complexes enable the abstraction of an electron from the 'd' orbital of the ruthenium centre which is then shifted to a π* orbital of the dppz ligand, resulting in the development of a long-lived 3 MLCT state which includes the initial population of 1 MLCT on the bipyridine portion of the dppz ligand, followed by intraligand electron transfer to the pyrazine moiety. 34 After that, again the formation of 3 MLCT at the phenazine-based pyrazine moiety of the dppz ligand may perhaps be the main cause of their exceptionally strong luminescence properties. 35,36 Herein, we wish to explore a novel series of substituted dipyrido[3,2-a:2′,3′-c]phenazine (dppz) based ruthenium(II)-p-cymene complexes as a potential delegate in the field of photoinduced cancer treatment.…”